Ä¢¹½Ö±²¥

GM plants no panacea

Opponents of GM technology will surely pounce on new patents from the US agrichemicals company Monsanto which admits that genetically engineering plants to resist pests is not a panacea. Novartis has already had doubts (New Ä¢¹½Ö±²¥, 18 December 1999, p 5) and now Monsanto’s patents (W0 02/28184/5) admit even more frankly that transgenic pest control “may not be desirable in the long termâ€� because it produces resistant strains and “numerous problems remain…under actual field conditionsâ€�. So they’re going for a belt-and-braces approach. Monsanto will now bioengineer maize to release endotoxins, but also treat the maize seed with the pesticides clothianidin and thiamethoxam. This, says Monsanto, has a synergistic effect with the endotoxin, giving increased resistance to corn rootworm.